Doxorubicin treatment of MDA-MB-157 breast cancer cells increased the cleavage of caspase-7 and PARP and decreased the level of AMPKα1 in a dose-dependent manner (Fig. 1a). The gene discussed is PRKAA1; the disease is breast cancer.